Anakoinosis Secondo Meeting Internazionale
La clinica, la biologia molecolare, la farmacologia, la patologia e l’istologia s’incontrano per spiegare e supportare il potenziale sviluppo della terapia antitumorale biomodulatoria
Comitato scientifico:
• Prof. Lina Ghibelli, Dep. of Biology, University of Rome
"Tor Vergata", Rome, Italy
• Prof. Albrecht Reichle, Dep. of Internal Medicine III, Haematology & Oncology, University Hospital,
Regensburg, Germany
• Prof. Christopher Gerner, Dep. of Analytical Chemistry, University of Vienna, Vienna, Austria
• Prof. Clara Nervi, Dep. of Medical and Surgical Sciences and Biotechnologies, University of Roma "La Sapienza", Rome, Italy
• Prof. Maria Teresa Voso, Dep. of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
• Dr. Gauthier Bouche, Anticancer Fund, Brussels, Belgium
•
Dr. Giulia Piaggio, Dep. of Research, Diagnosis and Innovative Technologies,
"Regina Elena" National Cancer Institute, Rome, Italy
